Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062174) titled 'A Multicenter Observational Study to Characterize Clonal Hematopoiesis in Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - NHO Nagoya Medical Center
Condition:
Condition - Hematologic diseases
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - To characterize clonal hematopoiesis and investigate its associations with transplant-related factors and post-transplant complications in long-term survivors after allogeneic hematopoietic stem cell transplantation.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who survived for at least 2 years after allogeneic hematopoietic stem cell transplantation, remained in complete remission, and provided written informed consent.
Key exclusion criteria - Patients with a history of relapse of the primary disease, suspected mixed chimerism, or those considered unsuitable for the study by the principal investigator.
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 07 Month 07 Day
Anticipated trial start date - 2026 Year 10 Month 01 Day
Last follow-up date - 2029 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071141
Disclaimer: Curated by HT Syndication.
